Global Type-1 Diabetes Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 200909
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Type-1 Diabetes Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Type-1 Diabetes Treatment size is estimated to be USD 6114.3 million in 2026 from USD 5165.4 million in 2020, with a change XX% between 2020 and 2021. The global Type-1 Diabetes Treatment market size is expected to grow at a CAGR of 4.3% for the next five years.

Market segmentation

Type-1 Diabetes Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Rapid-Acting Insulin

Short-Acting Insulin

Others

Market segment by Application, can be divided into

Hospitals & Clinics

Academic & Research Institutes

Market segment by players, this report covers

Astellas Pharma

Merck

Eli Lilly

Novo Nordisk

Sanofi

AstraZeneca

Boehringer Ingelheim GmbH

Novartis

Pfizer Inc.

Abbott Laboratories

Mannkind Corporation

Braun Melsungen AG

Macrogenics, Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Type-1 Diabetes Treatment

1.2 Classification of Type-1 Diabetes Treatment by Type

1.2.1 Overview: Global Type-1 Diabetes Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Type-1 Diabetes Treatment Revenue Market Share by Type in 2020

1.2.3 Rapid-Acting Insulin

1.2.4 Short-Acting Insulin

1.2.5 Others

1.3 Global Type-1 Diabetes Treatment Market by Application

1.3.1 Overview: Global Type-1 Diabetes Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals & Clinics

1.3.3 Academic & Research Institutes

1.4 Global Type-1 Diabetes Treatment Market Size & Forecast

1.5 Global Type-1 Diabetes Treatment Market Size and Forecast by Region

1.5.1 Global Type-1 Diabetes Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Type-1 Diabetes Treatment Market Size by Region, (2016-2021)

1.5.3 North America Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Type-1 Diabetes Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Type-1 Diabetes Treatment Market Drivers

1.6.2 Type-1 Diabetes Treatment Market Restraints

1.6.3 Type-1 Diabetes Treatment Trends Analysis

2 Company Profiles

2.1 Astellas Pharma

2.1.1 Astellas Pharma Details

2.1.2 Astellas Pharma Major Business

2.1.3 Astellas Pharma Type-1 Diabetes Treatment Product and Solutions

2.1.4 Astellas Pharma Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Astellas Pharma Recent Developments and Future Plans

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck Type-1 Diabetes Treatment Product and Solutions

2.2.4 Merck Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Merck Recent Developments and Future Plans

2.3 Eli Lilly

2.3.1 Eli Lilly Details

2.3.2 Eli Lilly Major Business

2.3.3 Eli Lilly Type-1 Diabetes Treatment Product and Solutions

2.3.4 Eli Lilly Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Eli Lilly Recent Developments and Future Plans

2.4 Novo Nordisk

2.4.1 Novo Nordisk Details

2.4.2 Novo Nordisk Major Business

2.4.3 Novo Nordisk Type-1 Diabetes Treatment Product and Solutions

2.4.4 Novo Nordisk Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novo Nordisk Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Type-1 Diabetes Treatment Product and Solutions

2.5.4 Sanofi Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 AstraZeneca

2.6.1 AstraZeneca Details

2.6.2 AstraZeneca Major Business

2.6.3 AstraZeneca Type-1 Diabetes Treatment Product and Solutions

2.6.4 AstraZeneca Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 AstraZeneca Recent Developments and Future Plans

2.7 Boehringer Ingelheim GmbH

2.7.1 Boehringer Ingelheim GmbH Details

2.7.2 Boehringer Ingelheim GmbH Major Business

2.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product and Solutions

2.7.4 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans

2.8 Novartis

2.8.1 Novartis Details

2.8.2 Novartis Major Business

2.8.3 Novartis Type-1 Diabetes Treatment Product and Solutions

2.8.4 Novartis Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Novartis Recent Developments and Future Plans

2.9 Pfizer Inc.

2.9.1 Pfizer Inc. Details

2.9.2 Pfizer Inc. Major Business

2.9.3 Pfizer Inc. Type-1 Diabetes Treatment Product and Solutions

2.9.4 Pfizer Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Pfizer Inc. Recent Developments and Future Plans

2.10 Abbott Laboratories

2.10.1 Abbott Laboratories Details

2.10.2 Abbott Laboratories Major Business

2.10.3 Abbott Laboratories Type-1 Diabetes Treatment Product and Solutions

2.10.4 Abbott Laboratories Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Abbott Laboratories Recent Developments and Future Plans

2.11 Mannkind Corporation

2.11.1 Mannkind Corporation Details

2.11.2 Mannkind Corporation Major Business

2.11.3 Mannkind Corporation Type-1 Diabetes Treatment Product and Solutions

2.11.4 Mannkind Corporation Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Mannkind Corporation Recent Developments and Future Plans

2.12 Braun Melsungen AG

2.12.1 Braun Melsungen AG Details

2.12.2 Braun Melsungen AG Major Business

2.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Product and Solutions

2.12.4 Braun Melsungen AG Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Braun Melsungen AG Recent Developments and Future Plans

2.13 Macrogenics, Inc.

2.13.1 Macrogenics, Inc. Details

2.13.2 Macrogenics, Inc. Major Business

2.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Product and Solutions

2.13.4 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Macrogenics, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Type-1 Diabetes Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Type-1 Diabetes Treatment Players Market Share

3.2.2 Top 10 Type-1 Diabetes Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Type-1 Diabetes Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Type-1 Diabetes Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Type-1 Diabetes Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Type-1 Diabetes Treatment Revenue Market Share by Application (2016-2021)

5.2 Type-1 Diabetes Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Type-1 Diabetes Treatment Revenue by Type (2016-2026)

6.2 North America Type-1 Diabetes Treatment Revenue by Application (2016-2026)

6.3 North America Type-1 Diabetes Treatment Market Size by Country

6.3.1 North America Type-1 Diabetes Treatment Revenue by Country (2016-2026)

6.3.2 United States Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Type-1 Diabetes Treatment Revenue by Type (2016-2026)

7.2 Europe Type-1 Diabetes Treatment Revenue by Application (2016-2026)

7.3 Europe Type-1 Diabetes Treatment Market Size by Country

7.3.1 Europe Type-1 Diabetes Treatment Revenue by Country (2016-2026)

7.3.2 Germany Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

7.3.3 France Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region

8.3.1 Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2016-2026)

8.3.2 China Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8.3.5 India Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Type-1 Diabetes Treatment Revenue by Type (2016-2026)

9.2 South America Type-1 Diabetes Treatment Revenue by Application (2016-2026)

9.3 South America Type-1 Diabetes Treatment Market Size by Country

9.3.1 South America Type-1 Diabetes Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country

10.3.1 Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Type-1 Diabetes Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Type-1 Diabetes Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Type-1 Diabetes Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Type-1 Diabetes Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Type-1 Diabetes Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Type-1 Diabetes Treatment Revenue Market Share by Region (2021-2026)

Table 6. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 7. Astellas Pharma Major Business

Table 8. Astellas Pharma Type-1 Diabetes Treatment Product and Solutions

Table 9. Astellas Pharma Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Merck Corporate Information, Head Office, and Major Competitors

Table 11. Merck Major Business

Table 12. Merck Type-1 Diabetes Treatment Product and Solutions

Table 13. Merck Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 15. Eli Lilly Major Business

Table 16. Eli Lilly Type-1 Diabetes Treatment Product and Solutions

Table 17. Eli Lilly Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 19. Novo Nordisk Major Business

Table 20. Novo Nordisk Type-1 Diabetes Treatment Product and Solutions

Table 21. Novo Nordisk Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Type-1 Diabetes Treatment Product and Solutions

Table 25. Sanofi Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 27. AstraZeneca Major Business

Table 28. AstraZeneca Type-1 Diabetes Treatment Product and Solutions

Table 29. AstraZeneca Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors

Table 31. Boehringer Ingelheim GmbH Major Business

Table 32. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product and Solutions

Table 33. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Novartis Corporate Information, Head Office, and Major Competitors

Table 35. Novartis Major Business

Table 36. Novartis Type-1 Diabetes Treatment Product and Solutions

Table 37. Novartis Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Inc. Major Business

Table 40. Pfizer Inc. Type-1 Diabetes Treatment Product and Solutions

Table 41. Pfizer Inc. Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 43. Abbott Laboratories Major Business

Table 44. Abbott Laboratories Type-1 Diabetes Treatment Product and Solutions

Table 45. Abbott Laboratories Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Mannkind Corporation Corporate Information, Head Office, and Major Competitors

Table 47. Mannkind Corporation Major Business

Table 48. Mannkind Corporation Type-1 Diabetes Treatment Product and Solutions

Table 49. Mannkind Corporation Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Braun Melsungen AG Corporate Information, Head Office, and Major Competitors

Table 51. Braun Melsungen AG Major Business

Table 52. Braun Melsungen AG Type-1 Diabetes Treatment Product and Solutions

Table 53. Braun Melsungen AG Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Macrogenics, Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Macrogenics, Inc. Major Business

Table 56. Macrogenics, Inc. Type-1 Diabetes Treatment Product and Solutions

Table 57. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global Type-1 Diabetes Treatment Revenue (USD Million) by Players (2019-2021)

Table 59. Global Type-1 Diabetes Treatment Revenue Share by Players (2019-2021)

Table 60. Breakdown of Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Type-1 Diabetes Treatment Players Head Office, Products and Services Provided

Table 62. Type-1 Diabetes Treatment Mergers & Acquisitions in the Past Five Years

Table 63. Type-1 Diabetes Treatment New Entrants and Expansion Plans

Table 64. Global Type-1 Diabetes Treatment Revenue (USD Million) by Type (2016-2021)

Table 65. Global Type-1 Diabetes Treatment Revenue Share by Type (2016-2021)

Table 66. Global Type-1 Diabetes Treatment Revenue Forecast by Type (2021-2026)

Table 67. Global Type-1 Diabetes Treatment Revenue by Application (2016-2021)

Table 68. Global Type-1 Diabetes Treatment Revenue Forecast by Application (2021-2026)

Table 69. North America Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)

Table 70. North America Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)

Table 71. North America Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)

Table 72. North America Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)

Table 73. North America Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)

Table 74. North America Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific Type-1 Diabetes Treatment Revenue by Region (2021-2026) & (USD Million)

Table 87. South America Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)

Table 88. South America Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)

Table 89. South America Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)

Table 90. South America Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)

Table 91. South America Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)

Table 92. South America Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa Type-1 Diabetes Treatment Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa Type-1 Diabetes Treatment Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa Type-1 Diabetes Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Type-1 Diabetes Treatment Picture

Figure 2. Global Type-1 Diabetes Treatment Revenue Market Share by Type in 2020

Figure 3. Rapid-Acting Insulin

Figure 4. Short-Acting Insulin

Figure 5. Others

Figure 6. Type-1 Diabetes Treatment Revenue Market Share by Application in 2020

Figure 7. Hospitals & Clinics Picture

Figure 8. Academic & Research Institutes Picture

Figure 9. Global Type-1 Diabetes Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Type-1 Diabetes Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Type-1 Diabetes Treatment Revenue Market Share by Region (2016-2026)

Figure 12. Global Type-1 Diabetes Treatment Revenue Market Share by Region in 2020

Figure 13. North America Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Type-1 Diabetes Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Type-1 Diabetes Treatment Market Drivers

Figure 19. Type-1 Diabetes Treatment Market Restraints

Figure 20. Type-1 Diabetes Treatment Market Trends

Figure 21. Astellas Pharma Recent Developments and Future Plans

Figure 22. Merck Recent Developments and Future Plans

Figure 23. Eli Lilly Recent Developments and Future Plans

Figure 24. Novo Nordisk Recent Developments and Future Plans

Figure 25. Sanofi Recent Developments and Future Plans

Figure 26. AstraZeneca Recent Developments and Future Plans

Figure 27. Boehringer Ingelheim GmbH Recent Developments and Future Plans

Figure 28. Novartis Recent Developments and Future Plans

Figure 29. Pfizer Inc. Recent Developments and Future Plans

Figure 30. Abbott Laboratories Recent Developments and Future Plans

Figure 31. Mannkind Corporation Recent Developments and Future Plans

Figure 32. Braun Melsungen AG Recent Developments and Future Plans

Figure 33. Macrogenics, Inc. Recent Developments and Future Plans

Figure 34. Global Type-1 Diabetes Treatment Revenue Share by Players in 2020

Figure 35. Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 3 Players Type-1 Diabetes Treatment Revenue Market Share in 2020

Figure 37. Global Top 10 Players Type-1 Diabetes Treatment Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Type-1 Diabetes Treatment Revenue Share by Type in 2020

Figure 40. Global Type-1 Diabetes Treatment Market Share Forecast by Type (2021-2026)

Figure 41. Global Type-1 Diabetes Treatment Revenue Share by Application in 2020

Figure 42. Global Type-1 Diabetes Treatment Market Share Forecast by Application (2021-2026)

Figure 43. North America Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)

Figure 44. North America Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)

Figure 45. North America Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)

Figure 46. United States Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)

Figure 50. Europe Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)

Figure 51. Europe Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)

Figure 52. Germany Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. France Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. United Kingdom Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Russia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Italy Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Asia-Pacific Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)

Figure 58. Asia-Pacific Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)

Figure 59. Asia-Pacific Type-1 Diabetes Treatment Revenue Market Share by Region (2016-2026)

Figure 60. China Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South Korea Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)

Figure 67. South America Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)

Figure 68. South America Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Type (2016-2026)

Figure 72. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Application (2016-2026)

Figure 73. Middle East and Africa Type-1 Diabetes Treatment Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. UAE Type-1 Diabetes Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz